Analysis of the Mediating Effect of Vitamin D via the TGF‐β1/Treg Pathway in the Pathogenesis of Childhood Primary Immune Thrombocytopenia

Read full text Summarise with VIRAT
Authors: Peiling Li, Mengru Chen, Zhihang Wang, Rui Fan, Jia Guo, Bao Liu, Zhiyin Wang, Yanyan Ma, Dongju Zhao, Shujun Li
Cited by: 0
References: 33

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVE: To investigate the role of vitamin D (VitD), transforming growth factor-β1 (TGF-β1), and regulatory T cells (Treg) in the pathogenesis of primary immune thrombocytopenia (ITP) in children. METHODS: From February 2023 to September 2024, 51 children with ITP and 44 healthy children from the First Affiliated Hospital of Xinxiang Medical College were enrolled. The serum levels of VitD and TGF-β1 and the percentage of Treg cells in peripheral blood were measured. RESULTS: There was no significant difference in age and sex between the two groups (p > 0.05). ITP group VitD, TGF-β1, and the level of Treg cells were significantly lower than those of the control group (p < 0.05). In the ITP group, VitD and TGF-β1 (r = 0.421), Treg cells (r = 0.516), TGF-β1 and Treg cells (r = 0.563), and platelet count (r = 0.399, 0.305, 0.361, respectively, p < 0.05). The median model analysis showed that VitD had a significant negative overall effect on ITP risk (regression coefficient = -0.014, p = 0.004), but its direct effect was no longer significant after the introduction of TGF-β1 and Treg, suggesting a complete mediation effect, where the path of VitD affecting ITP via TGF-β1 is significant (effect value = -0.015, p < 0.001), but the mediated pathway involving Treg was not statistically significant. CONCLUSION: There is dysregulation of VitD, TGF-β1, and Treg cells in newly diagnosed children with ITP. TGF-β1 may be a key mediator of the regulation of ITP by VitD, suggesting the potential value of TGF- β1 as an intervening target.

Fields of Study & Subjects

Platelet Disorders and Treatments T-cell and B-cell Immunology Complement system in diseases

Publication details

Journal / source
Journal of Immunology Research
Volume
2026
Issue
1
Pages
e4001873–e4001873
Publication date
1 January 2026
Language
EN